share_log

和鉑醫藥-B：授出購股權及授出股份獎勵

HBM HOLDINGS-B: GRANT OF SHARE OPTIONS AND GRANT OF SHARE AWARDS

香港交易所 ·  Apr 3 07:03
Summary by Moomoo AI
和鉑醫藥-B於2024年4月3日宣佈，根據股東於2020年11月23日採納的購股權計劃及股份獎勵計劃，向16名合資格參與者（包括14名非關連僱員及2名董事）授出總計8,308,000份購股權及向14名非關連僱員授出3,105,000份股份獎勵。購股權的行使價格為每股1.36港元，並設有績效考核機制，購股權及獎勵的50%將於2024年4月3日歸屬，其餘50%將於2025年4月3日歸屬。此舉旨在鼓勵參與者提升公司及其股份的價值，並與公司及股東的整體利益保持一致。授出的購股權及獎勵均無需經股東批准，且不會導致超過已發行股份的1%。該計劃符合2023年1月1日上市規則新訂第17章的過渡安排。
和鉑醫藥-B於2024年4月3日宣佈，根據股東於2020年11月23日採納的購股權計劃及股份獎勵計劃，向16名合資格參與者（包括14名非關連僱員及2名董事）授出總計8,308,000份購股權及向14名非關連僱員授出3,105,000份股份獎勵。購股權的行使價格為每股1.36港元，並設有績效考核機制，購股權及獎勵的50%將於2024年4月3日歸屬，其餘50%將於2025年4月3日歸屬。此舉旨在鼓勵參與者提升公司及其股份的價值，並與公司及股東的整體利益保持一致。授出的購股權及獎勵均無需經股東批准，且不會導致超過已發行股份的1%。該計劃符合2023年1月1日上市規則新訂第17章的過渡安排。
PLATINUM PHARMACEUTICAL-B ANNOUNCED ON 3 APRIL 2024 THAT IT HAS GRANTED A TOTAL OF 8,308,000 SHARE OPTIONS TO 16 ELIGIBLE PARTICIPANTS (INCLUDING 14 UNRELATED EMPLOYEES AND 2 DIRECTORS) TO 16 ELIGIBLE PARTICIPANTS (INCLUDING 14 UNRELATED EMPLOYEES AND 2 DIRECTORS) UNDER THE SHARE OPTION PLAN AND SHARE AWARD SCHEME ADOPTED BY SHAREHOLDERS ON 23 NOVEMBER 2020 AND GRANTED 3,105,000 SHARES TO 14 NON-RELATED EMPLOYEES Portion of rewards. The exercise price of the share option is HK$1.36 per share and is subject to a performance review mechanism. 50% of the share option and bonus will be vested on 3 April 2024 and the remaining 50% will be vested on 3 April 2025. This initiative is designed to encourage participants to enhance the value of the company and its shares and to align with the overall interests of the company and its shareholders. The warrants and rewards granted are not subject to shareholder approval and will not result in more than 1% of the issued shares. The plan complies with the transitional arrangement of Chapter 17 of the Listing Rules updated on January 1, 2023.
PLATINUM PHARMACEUTICAL-B ANNOUNCED ON 3 APRIL 2024 THAT IT HAS GRANTED A TOTAL OF 8,308,000 SHARE OPTIONS TO 16 ELIGIBLE PARTICIPANTS (INCLUDING 14 UNRELATED EMPLOYEES AND 2 DIRECTORS) TO 16 ELIGIBLE PARTICIPANTS (INCLUDING 14 UNRELATED EMPLOYEES AND 2 DIRECTORS) UNDER THE SHARE OPTION PLAN AND SHARE AWARD SCHEME ADOPTED BY SHAREHOLDERS ON 23 NOVEMBER 2020 AND GRANTED 3,105,000 SHARES TO 14 NON-RELATED EMPLOYEES Portion of rewards. The exercise price of the share option is HK$1.36 per share and is subject to a performance review mechanism. 50% of the share option and bonus will be vested on 3 April 2024 and the remaining 50% will be vested on 3 April 2025. This initiative is designed to encourage participants to enhance the value of the company and its shares and to align with the overall interests of the company and its shareholders. The warrants and rewards granted are not subject to shareholder approval and will not result in more than 1% of the issued shares. The plan complies with the transitional arrangement of Chapter 17 of the Listing Rules updated on January 1, 2023.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more